MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Successful treatment of Stiff Person Syndrome with botulinum toxin

A. Gonçalves, F. Brunet, D. Ariton, O. de Fabregues (Loures, Portugal)

Meeting: 2022 International Congress

Abstract Number: 87

Keywords: Botulinum toxin: Clinical applications: other, Stiff-person syndrome

Category: Other

Objective: Describe a case of Stiff Person Syndrome (SPS) treated with botulinum toxin injection and alert to the utility of botulinum toxin in this disorder.

Background: SPS is a rare autoimmune entity characterized by progressive muscle stiffness and spasticity involving predominantly axial and proximal limb muscles, leading to pain and gait impairment. Although the exact pathophysiology remains unknown, the most frequently identified antibodies are against GAD, glycineR, DPPX, GABAAR, gephyrin and amphipysin.

Method: Case report.

Results: A 48-year-old woman with past medical history of Hashimoto’s thyroiditis, systemic lupus erythematosus and recent diagnosis of latent autoimmune diabetes in adults (LADA) with positive pancreatic autoantibodies (IA-2). She was admitted with an history of insidiously lower “back pain”, lumbar rigidity, episodic painful spasms, walking difficulty and inability to climb stairs.
On examination she had a board-like rigidity of paraspinal muscles (erectors of the spine), abnormal axial posture with increased lumbar hyperlordosis. Serum testing revealed elevated anti-GAD antibodies (>250 IU/mL), the lumbar MRI showed hyperlordosis and the brain MRI was unremarkable. A paraneoplastic origin was excluded through CT scan of the thorax, abdomen, mammography, and whole-body PET scan. The patient refused treatment with immunoglobulin IV. Treatment with baclofen and gabapentin was tried, but only provided partial relief. Botulinum neurotoxin type A-ABO was injected at three levels (L3–L5) into the paraspinal muscles bilaterally, 30-35 units in each point, for a total of 200 units. Within two weeks, the patient reported partial response. Six months later a second treatment was performed, and 500 units were applied. The patient had a marked reduction in muscle spasms along with significative improvement of ambulation. On examination a reduction in the board-like rigidity of paraspinal muscles was noted.
She was then able to practice Pilates and walk at least 30 minutes a day. The control EMG was normal.

Conclusion: Treatment with Botulinum toxin injection in this case was used with clear improvement. Some reports have validated the safety and utility of botulinum injections in this setting, yet botulinum remains underutilized.

To cite this abstract in AMA style:

A. Gonçalves, F. Brunet, D. Ariton, O. de Fabregues. Successful treatment of Stiff Person Syndrome with botulinum toxin [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/successful-treatment-of-stiff-person-syndrome-with-botulinum-toxin/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/successful-treatment-of-stiff-person-syndrome-with-botulinum-toxin/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley